Диссертация (1139530), страница 33
Текст из файла (страница 33)
1005-1012.267181. Chakrabarti B, Calverley PMA, Davis PDO. Tuberculosis and itsincidence, special nature, and relationship with chronic obstructivepulmonary disease. // Int J COPD. - 2007. - Vol 2. – N.3. –P.263-272.182. Chamla D. The assessment of patients' health-related quality of lifeduring tuberculosis treatment in Wuhan, China. // Int J Tuberc Lung Dis. –2004. - Vol.8. – N.9.
– P.1100-1106.183. Chetta A, Zanini A, Pisi G, et al. Reference values for the 6-min walktest in healthy subjects 20-50 years old. // Respir Med. - 2006. – Vol.100.– N.9. – P. 1573-1578.184. Chetta A, Pisi G, Aiello M, et al. The walking capacity assessment in therespiratory patient. // Respiration. – 2009.
– Vol. 77. – N.4. - P.361-367.185. Chuang ML, Lin IF, Wasserman K. The body weight walking distanceproduct as related to lung function, anaerobic threshold and peak VO2 inCOPD patients. // Respir Med. – 2001. – Vol. 95. – N.7. - P. 618–626.186.Chung KP, Chen JY, Lee CH, Wu HD, Wang JY, Lee LN, Yu CJ, YangPC; TAMI Group. Trends and predictors of changes in pulmonary functionafter treatment for pulmonary tuberculosis. // Clinics.
– 2011. Vol.66. –N.4. - P. 549-556.187. Cooper KH. A means of assessing maximal oxygen intake. Correlationbetween field and treadmill testing. // JAMA. – 1968. – Vol.203. – N.3. –P.201-204.188. Cote CG, Celli BR. Predictors of mortality in chronic obstructivepulmonary disease. // Clin Chest Med. – 2007. - - Vol.28. - N.3 – P.515524.189. Cote CG, Casanova C, Marín JM, et al. Validation and comparison ofreference equations for the 6-min walk distance test. // Eur Respir J. –2008. – Vol.31. – N.3. – P.
571-578.190. Crapo RO. Pulmonary function testing. // N Engl J Med. - 1994.Vol.331. - N.1. - P.25-30.268191. Criée CP, Sorichter S, Smith HJ, Kardos P, Merget R, Heise D, BerdelD, Köhler D, Magnussen H, Marek W, Mitfessel H, Rasche K, Rolke M,Worth H, Jörres RA; Working Group for Body Plethysmography of theGermanSocietyforPneumologyandRespiratoryCare.Bodyplethysmography--its principles and clinical use. // Respir Med. – 2011. –Vol.105. – N.7. – P.959-971.192. Cukic V.
Reduction of pulmonary function after surgical lung resectionsof different volume. // Med Arch. – 2014. – Vol.68. – N.4. – P. 231-235.193. D'Aquino LC, Rodrigues SC, Barros JA, Rubin AS, Rosário Filho NA,Pereira CA. Predicting reduced TLC in patients with low FVC and anormal or elevated FEV1/FVC ratio. // J Bras Pneumol. – 2010. –Vol.36. –N.4. P.460-467.194. de Torres JP, Pinto-Plata V, Ingenito E, Badley P, Grey A, Berger R,Celli B.
Power of outcome measurements to detect clinically significantchanges in pulmonary rehabilitation of patients with COPD. // Chest. 2002. - Vol. 121. - N. 4. – P. 1092-1098.195. Derom E, van Weel C, Liistro G, Buffels J, Schermer T, Lammers E,Wouters E, Decramer M. Primary care spirometry.
// Eur Respir J. – 2008.– Vol.31. – N.1. – P.197-203.196. de Vallière S, Barker RD. Residual lung damage after completion oftreatment for multidrug-resistant tuberculosis. // Int J Tuberc Lung Dis. –2004. – Vol.8. – N.6. – P.767-771.197. Deyo RA, Diehr P, Patrick DL. Reproducibility and responsiveness ofhealth status measures. Statistics and strategies for evaluation.
// ControlClin Trials. – 1991. – Vol.12. – N.4 Suppl. – P.142S-158S.198. Dheda K, Booth H, Huggett JF, Johnson MA, Zumla A, Rook GA. Lungremodeling in pulmonary tuberculosis. // J Infect Dis. – 2005. – Vol.192. –N.7. – P.1201-1209.269199. Diaz-Guzman E, Mannino D. Epidemiology and prevalence of chronicobstructive pulmonary disease.
// Clin Chest Med. – 2014. – Vol. 35. – N.1.– P.7-16.200.Domingo-Salvany A, Lamarca R, Ferrer M, Garcia-Aymerich J, AlonsoJ, Félez M, Khalaf A, Marrades RM, Monso E, Serra-Batlles J, and AntoJM. Health-related quality of life and mortality in male patients withchronic obstructive pulmonary disease. // Am J Respir Crit Care Med. –2002. – Vol.166. - N.5. – P.680-685.201.
Donner CF, Muir JF, Rehabilitation and chronic care scientific group ofthe European Respiratory Society. Selection criteria and programmes forpulmonary rehabilitation in COPD patients. // Eur Respir J. - 1997. Vol.10. - N.3. - P.744-757.202. Eakin EG, Resnikoff PM, Prewitt LM, Ries AL, Kaplan RM.
Validationof a new dyspnea measure. The UCSD Shortness of Breath Questionnaire.// Chest. - 1998. - Vol. 113. – N. 3. - P.619-623.203. Ehrlich RI, White N, Norman R, Laubscher R, Steyn K, Lombard C,Bradshaw D. Predictors of chronic bronchitis in South African adults. // IntJ Tuberc Lung Dis. – 2004. – Vol.8. – N.3. – P.369-376.204. Ehrlich RI, Adams S, Baatjies R, Jeebhay MF. Chronic airflowobstruction and respiratory symptoms following tuberculosis: a review ofSouth African studies. // Int J Tuberc Lung Dis.
– 2011. – Vol.15. – N.7. –P.886-891.205. Engstrom CP, Persson LO, Larsson S, Sullivan M. Health-relared qualityof life in COPD: why both disease-specific and generic measures should beused. // Eur Respir J. – 2001. – Vol. 18. – N.1. – P.69-76.206. Enright PL, Sherill DL. Reference equations for the six-minute walk inhealthy adults. // Am J Respir Crit Care Med.
- 1998. - Vol.158 – N.5 Pt 1.- P.1384 - 1387.270207. Enright PL, McBurnie MA, Bittner V, Tracy RP, McNamara R, ArnoldA, and Newman AB. The 6-min walk test. A quick measure of functionalstatus in elderly adults. // Chest. - 2003. – Vol.123. – N2. – P.387-398.208. Erikssen G. Physical fitness and changes in mortality: the survival of thefittest. // Sports Med. – 2001. – Vol.31.
– N.8. – P.571–576.209. Fleg JL, Piña IL, Balady GJ, et al. Assessment of functional capacity inclinical and research applications: An advisory from the Committee onExercise, Rehabilitation, and Prevention, Council on Clinical Cardiology,American Heart Association. // Circulation. – 2000. – Vol.102. – N.13. – P.1591-1597.210. Flesch JD, Dine CJ. Lung volumes: measurement, clinical use, andcoding.
// Chest. – 2012. – Vol.142. – N.2. - P.506-510.211. Fletcher CM.The clinical diagnosis of pulmonary emphysema: anexperimental study. // Proc. Res. Sot. Med. – 1952. - Vol. 45. – N.9. P.577-584.212. Fletcher CM, Elmes PC, Wood CH. The significance of respiratorysymptoms and the diagnosis of chronic bronchitis in a working population.// BMJ. - 1959. - N.
5147. - P. 257-266.213. Frost AE, Langleben D, Oudiz R, et al. The 6-min walk test (6MW) asan efficacy endpoint in pulmonary arterial hypertension clinical trials:demonstration of a ceiling effect. // Vascul Pharmacol. – 2005. – Vol.43. –N.1. - P. 36-39.214. Gaensler EA, Cugell DW, Lindgren I et al: The role of pulmonaryinsufficiency in mortality and invalidism following surgery for pulmonarytuberculosis.
// J Thorac Surg. – 1955. – Vol.29. – N.2. – P.163-187.215. Gershon AS, Warner L, Cascagnette P, Victor JC, To T. Lifetime risk ofdeveloping chronic obstructive pulmonary disease: a longitudinalpopulation study. // Lancet. – 2011. - Vol.378. - N.9795. - P.991-996.271216. Ghosh CS, Win R, Kumar R, David R, Prabhu D. Assessment ofrespiratory morbidity among pulmonary TB patients treated under RNTCP.// Pulmon. – 2006.
- Vol.8. – N.2. - P.51-54.217.Gibbons WJ, Fruchter N, Sloan S, Levy RD. Reference values for amultiple repetition 6-minute walk test in healthy adults older than 20 years.// J Cardiopulm Rehabil. – 2001. – Vol.21. – N.2. – P.87-93.218. Glady CA, Aaron SD, Lunau M, Clinch J, Dales RE. A spirometrybased algorithm to direct lung function testing in the pulmonary functionlaboratory.
// Chest. – 2003. – Vol.123. – N.6. – P.1939-1946.219. Guo N, Marra F, Marra CA. Measuring health-related quality of life intuberculosis: a systematic review. // Health Qual Life Outcomes. – 2009. –Vol.18. – N.7. – P.14.220. Guyatt GH, Sullivan MJ, Thompson PJ, et al.
The 6-minute walk: anew measure of exercise capacity in patients with chronic heart failure. //Can Med Assoc J. – 1985. – Vol.132. – N.8. – P.919-923.221. Guyatt G, Bombardier C, Tugwell PX. Measuring disease-specificquality of life in clinical trials. // Can Med Assoc J. – 1986. –Vol.134. –N.8. - P.889-895.222. Guyatt GN, Berman LB, Townsend M, Pugsley S, Chambers LW. Ameasure of quality of life for clinical trials in chronic lung disease. //Thorax. - 1987. - Vol.42. – N.10.
- P. 773-778.223. Guyatt GN, Townsend M, Keller J, Singer J, Nogradi S. Measuringfunctional status in chronic lung disease: conclusions from a randomizedcontrol trial. // Respiratory Medicine. -1989. - Vol.83. - N.4. - P.293-297.224. Guyatt GH, Feeny DH, Patrick DL. Measuring health-related quality oflife: Basic Sciences Review. // Ann Intern Med.
- 1993-Vol. 118 –N.8. P.622-629.225. Guyatt GH, Naylor D, Juniper EF, Heyland D, Cook D and the Evidence–Based Medicine Working Group. Users’ guides to medical literature. IX272How to use an article about health-related quality of life. // JAMA.
– 1997.– Vol. 277. - N.15. - P.1232-1237.226. Hajiro T, Nishimura K, Tsukino M, Ikeda A, Koyama H, Izumi T.Comparisonofdiscriminativepropertiesamongdisease-specificquestionnaires for measuring health-related quality of life in patients withchronic obstructive pulmonary disease. // Am J Respir Crit Care Med. –1998. – Vol.157. – N.3 Pt 1. – P.785-790.227. Hajiro T, Nishimura K, Tsukino M, Ikeda A, Oga T, Izumi T.
![](https://s.studizba.com/z.php?f=/templates/si/i/noavatar.png&w=100&h=100&t=1"){kind=avatar}
